SciELO - Scientific Electronic Library Online

 
vol.34 número4Factores predictivos de daño renal en la infección febril del tracto urinario: utilidad de la procalcitonina¿Qué intervenciones terapéuticas durante el estadio prediálisis de la enfermedad renal crónica se asocian a una mejor supervivencia en diálisis? índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nefrología (Madrid)

versión On-line ISSN 1989-2284versión impresa ISSN 0211-6995

Resumen

LORENZO-SELLARES, Víctor et al. Cost analysis and sociocultural profile of kidney patients: impact of the treatment method. Nefrología (Madr.) [online]. 2014, vol.34, n.4, pp.458-468. ISSN 1989-2284.  http://dx.doi.org/10.3265/Nefrologia.pre2014.Apr.12501.

Background: The cost analysis of chronic kidney disease based on individual data for treatment methods and components has not been published in Spain. Objectives: a) To study the health costs of a year of treatment with haemodialysis (HD), deceased donor renal transplantation (RTx), renal-pancreas transplantation (RPTx), and S4 and S5 advanced chronic kidney disease (ACKD) b) Assess the potential relationship between sociocultural diversity, costs and treatment method. Methods: Observational study of: 1) 81 patients with ACKD (53 S4 and 28 S5) 2) 162 with more than 3 months on HD and 3) 173 with a Tx for more than 6 months (140 RTx and 33 RPTx). The costs were assessed in five categories: 1) HD sessions, 2) drug intake, 3) hospitalisation, 4) outpatient care and 5) transportation. We carried out a survey with socio-demographic parameters. Results: The financial impact of HD was €47,714±18,360 (mean±SD), that of Tx €13,988±9970, and that of ACKD €9654±9412. The cost of HD was the highest in all financial items. The costs were similar between RTx and RPTx. In ACKD, the greater the renal deterioration, the greater the cost is (S4 €7846±8901 versus S5 €13,300±9820, P<.01). Tx patients had the best sociocultural status, while HD patients had the worst profile. We did not find differences in costs between the three sociocultural groups. Conclusions: HD has the greatest financial impact in all items, five times higher than the ACKD patient cost and three times than the Tx patient cost. Optimising early prevention and Tx, if appropriate, must be priority strategies. This analysis invites us to think about whether sociocultural status can have an influence on opportunities for Tx.

Palabras clave : Costs-of-illness; Economic evaluation; Advanced chronic kidney disease; Haemodialysis; Kidney transplant; Diagnosis-related groups; Sociocultural level.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons